Peter Hein

Part of SaveLend Group AB, Billecta AB is a private company that provides a complete invoicing program for small businesses. The company is based in Stockholm, Sweden. Billecta was acquired by Savelend Sweden AB on September 19, 2018 for $4.49 million. Billecta automates the entire invoicing process, from billing to payment collection, and offers features such as claims management, reminder management, and API and integration capabilities. The Swedish company was founded by Jonas Ahlberg and Jacob Gevcen.

Hein & Oetting Feinwerktechnik GmbH designs and manufactures precision mechatronics and precision engineering. It offers fine mechanical components, assembly groups, and finished goods in small and medium series. The firm specializes on above-average, demanding technical products in highest precision focused on chipping and assembly. The products of the firm are 3D-Computer Aided Design and Computer Aided Manufacturing systems for the consulting and engineering industry. The company was founded by Ernst Oetting und Peter Hein in 1970 and is headquartered in Hamburg, Germany.

Granngården AB retails garden and agriculture supplies. The firm sells its products in four areas: animal and pet owners, garden and house owners, farmers and forest managers, and other businesses. It operates a mail order under the Nordpost brand and an electronic commerce via granngården.se. The company was founded in 1880 and is headquartered in Malmo, Sweden.

Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden.

Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.